I examine the importance of physicians in the process by which patients receive either trade-name or generic drugs …. Using a dataset on physicians, their patients, and the multisource drugs prescribed, I find that almost all physicians … prescribe both types of drugs to their patients, but some physicians are more likely to prescribe generic drugs while other …

prescription products to physicians at a less expensive way than traditional detailing. In the proposed promotion response model …

Physicians’ generic pharmaceutical adoption involves not only patients’ and insurance payers’ cost, but also their own … interests. This study examines this double agency problem for physicians by using Taiwanese data because two of its … institutional features: First, patients and physicians in a universal health care system did not self-select their insurance plans …

We ask how competition influences the prescribing practices of physicians. Law changes granting nurse practitioners … variation in competition. In response, we find that general practice physicians (GPs) significantly increase their prescribing …. Our findings are consistent with a simple model of physician behavior in which competition for patients leads physicians …

established in the community for it to be prescribed more heavily by specialists and target physicians in solo practice and newer … physicians to speed up the adoption process. Furthermore, for newer drugs traditional forms of detailing via a live sales rep are …

condition for designing effective policies is to identify who drives antibiotic treatment decisions, physicians or patient …

Physicians commonly receive marketing-related transfers from drug firms. We examine the impact of these relationships … fading out within a year. A marketing payment also leads physicians to begin treating cancer patients with lower expected …